EcoDrugPlus

5-Hydroxytryptamine (Serotonin) Receptor 2a, Genome Duplicate B

Ensembl ID : ENSDARG00000058165
Gene Symbol: HTR2AB
5 Cross references
205 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b, G Protein-Coupled

Ensembl ID : ENSDARG00000115925
Gene Symbol: HTR2B
8 Enzyme and pathways 5 Cross references
203 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 1

Ensembl ID : ENSDARG00000018228
Gene Symbol: HTR2CL1
8 Enzyme and pathways 5 Cross references
201 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2c, G Protein-Coupled-Like 2

Ensembl ID : ENSDARG00000013210
Gene Symbol: HTR2CL2
5 Cross references
154 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 3a

Ensembl ID : ENSDARG00000089212
Gene Symbol: HTR3A
3 Enzyme and pathways 5 Cross references
205 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 3b

Ensembl ID : ENSDARG00000061749
Gene Symbol: HTR3B
3 Enzyme and pathways 3 Cross references
175 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a, Genome Duplicate A

Ensembl ID : ENSDARG00000038869
Gene Symbol: HTR5AA
8 Enzyme and pathways 5 Cross references
202 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a, Genome Duplicate B

Ensembl ID : ENSDARG00000068557
Gene Symbol: HTR5AB
8 Enzyme and pathways 5 Cross references
202 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 6

Ensembl ID : ENSDARG00000016095
Gene Symbol: HTR6
8 Enzyme and pathways 5 Cross references
115 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 7a

Ensembl ID : ENSDARG00000056949
Gene Symbol: HTR7A
8 Enzyme and pathways 5 Cross references
196 Possible Orthologues:

5-Hydroxytryptamine Receptor 4

Ensembl ID : ENSDARG00000061940
Gene Symbol: HTR4
8 Enzyme and pathways 5 Cross references
201 Possible Orthologues:

5-Hydroxytryptamine Receptor 7

Ensembl ID : ENSDARG00000099854
Gene Symbol: HTR7
6 Cross references
152 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).